» Articles » PMID: 35807321

An Investigation to Explore Anti-Cancer Potential of Mill. Phytoconstituents for the Management of Human Breast Cancer

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Jul 9
PMID 35807321
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is one of the most prevalent cancers in the world. Traditionally, medicinal plants have been used to cure various types of diseases and disorders. Based on a literature survey, the current study was undertaken to explore the anticancer potential of Mill. phytoconstituents against breast cancer target protein (PDB ID: 6CHZ) by the molecular docking technique. Molecular docking was done using Autodock/vina software. Toxicity was predicted by the Protox II server and drug likeness was predicted by Molinspiration. 100 ns MD simulation of the best protein-ligand complexes were done using the Amber 18 tool. The present molecular docking investigation has revealed that among the 40 selected phytoconstituents of , α-pinene and D-limonene showed best binding energy (-6 and -5.9 kcal/mol respectively) with the breast cancer target. α-Pinene and D-limonene followed all the parameters of toxicity, and 100 ns MD simulations of α-pinene and D-limonene complexes with 6CHZ were found to be stable. α-Pinene and D-limonene can be used as new therapeutic agents to cure breast cancer.

Citing Articles

Exploring the Therapeutic Potential for Breast Cancer of Phytochemicals and Secondary Metabolites in Marjoram, Thyme, and Persimmon.

Mattingly A, Vickery Z, Ivankovic D, Farrell C, Hakonarson H, Nguyen K Metabolites. 2024; 14(12).

PMID: 39728433 PMC: 11678518. DOI: 10.3390/metabo14120652.


design of novel bioactive molecules to treat breast cancer with chlorogenic acid derivatives: a computational and SAR approach.

Sehrawat R, Rathee P, Rathee P, Khatkar S, Akkol E, Khatkar A Front Pharmacol. 2023; 14:1266833.

PMID: 38152692 PMC: 10751932. DOI: 10.3389/fphar.2023.1266833.


Novel biogenic silver nanoconjugates of Abrus precatorius seed extracts and their antiproliferative and antiangiogenic efficacies.

Kaur A, Sharma Y, Singh G, Kumar A, Kaushik N, Khan A Sci Rep. 2023; 13(1):13514.

PMID: 37598190 PMC: 10439965. DOI: 10.1038/s41598-023-40079-8.


In Vitro Approaches to Explore the Anticancer Potential of One Natural Flavanone and Four Derivatives Loaded in Biopolymeric Nanoparticles for Application in Topical Delivery Treatments.

Bustos-Salgado P, Andrade-Carrera B, Dominguez-Villegas V, Noe V, Mallandrich M, Colom H Pharmaceutics. 2023; 15(6).

PMID: 37376079 PMC: 10301461. DOI: 10.3390/pharmaceutics15061632.


A Comparative UHPLC-Q-Trap-MS/MS-Based Metabolomics Analysis to Distinguish Cultivars' Antioxidant Extracts.

Crescenzi M, DUrso G, Piacente S, Montoro P Molecules. 2023; 28(2).

PMID: 36677955 PMC: 9863134. DOI: 10.3390/molecules28020900.


References
1.
Wang J, Wolf R, Caldwell J, Kollman P, Case D . Development and testing of a general amber force field. J Comput Chem. 2004; 25(9):1157-74. DOI: 10.1002/jcc.20035. View

2.
Kim D, Han S, Go B, Oh U, Kim C, Jung Y . 2-Methoxy-4-vinylphenol Attenuates Migration of Human Pancreatic Cancer Cells Blockade of FAK and AKT Signaling. Anticancer Res. 2019; 39(12):6685-6691. DOI: 10.21873/anticanres.13883. View

3.
Sun J . D-Limonene: safety and clinical applications. Altern Med Rev. 2007; 12(3):259-64. View

4.
Frisch R, Snow R, Johnson L, Gerard B, Barbieri R, Rosen B . Magnetic resonance imaging of overall and regional body fat, estrogen metabolism, and ovulation of athletes compared to controls. J Clin Endocrinol Metab. 1993; 77(2):471-7. DOI: 10.1210/jcem.77.2.8345054. View

5.
Xu C, Wu P, Gao J, Zhang L, Ma T, Ma B . Heptadecanoic acid inhibits cell proliferation in PC‑9 non‑small‑cell lung cancer cells with acquired gefitinib resistance. Oncol Rep. 2019; 41(6):3499-3507. DOI: 10.3892/or.2019.7130. View